-
COST-EFFECTIVENESS ANALYSIS OF PET-GUIDED DE-ESCALATION FOR HER2 POSITIVE EARLY BREAST CANCER IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
UNIVERSAL MATERNAL IMMUNIZATION AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) IN BRAZIL: AN EXTENDED COST-EFFECTIVENESS ANALYSIS AT THE REGIONAL LEVEL
Aug 11, 2026, 17:16 PM -
THE ECONOMIC BURDEN OF SEIZURE EMERGENCIES IN SPAIN: RESULTS FROM A COST OF ILLNESS STUDY
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS AND BUDGET IMPACT ANALYSIS FOR PIRTOBRUTINIB VERSUS IDELALISIB PLUS RITUXIMAB AS THIRD-LINE TREATMENT IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS IN THE NETHERLANDS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF COENZYME Q10 ADDED TO LIFESTYLE MODIFICATION IN METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE: EVIDENCE FROM A RANDOMIZED CONTROLLED TRIAL
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND VALIDATION OF A VARIABLE-BASED AI PROMPT FRAMEWORK FOR AUTOMATED GENERATION OF AMNOG DOSSIER SECTIONS: A MULTI-DRUG SOURCE FIDELITY EVALUATION
Aug 11, 2026, 17:16 PM -
HUMAN VERSUS ARTIFICIAL INTELLIGENCE FOR DATA EXTRACTION IN SYSTEMATIC LITERATURE REVIEWS: A REVIEW OF ACCURACY, EFFICIENCY, AND THE EVOLVING ROLE OF HUMAN REVIEWERS
Aug 11, 2026, 17:16 PM -
A TARGETED LITERATURE REVIEW TO IDENTIFY PATIENT-REPORTED SYMPTOMS ASSOCIATED WITH BREAST CANCER DISEASE PROGRESSION
Aug 11, 2026, 17:16 PM -
INCORPORATING EQUITY INTO VACCINE DECISION-MAKING IN BRAZIL: A DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS OF MATERNAL RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC BURDEN OF METASTATIC UVEAL MELANOMA: A RETROSPECTIVE ANALYSIS OF COMMERCIALLY-INSURED, MEDICARE, AND MEDICAID PATIENTS IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
RESIDUAL CONFOUNDING IN REAL-WORLD EXTERNAL CONTROL ARMS: AN UPDATED NICE APPRAISAL REVIEW
Aug 11, 2026, 17:16 PM -
DNA-DAMAGING EFFECT OF IMAZALIL, PYRIMETHANIL AND THIABENDAZOLE IN THE COMET ASSAY TEST - WITH AND WITHOUT LEMON OIL
Aug 11, 2026, 17:16 PM -
PATIENT-LEVEL SIMULATION MODELS FOR COST-EFFECTIVENESS ANALYSIS IN MULTIPLE SCLEROSIS: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
ACCEPTED COST PER QALY IN SWEDISH REIMBURSEMENT DECISIONS: NOMINAL STABILITY BUT REAL DECLINE
Aug 11, 2026, 17:16 PM -
INDIRECT TREATMENT COMPARISONS IN DUTCH HEALTH TECHNOLOGY ASSESSMENT: EVOLVING METHODOLOGICAL EXPECTATIONS FROM 2017 TO 2025
Aug 11, 2026, 17:16 PM -
IS LENACAPAVIR-BASED PREP AN EFFICIENT AND AFFORDABLE SOLUTION IN A FRENCH CONTEXT? A COST-UTILITY AND BUDGET IMPACT ANALYSIS
Aug 11, 2026, 17:16 PM -
PRESCRIBER INTENT VERSUS TREATMENT INITIATION FOR BIOLOGIC THERAPIES IN ATOPIC DERMATITIS: A REAL-WORLD ANALYSIS USING NORSTELLALINQ US LINKED E-PRESCRIPTION, CLAIMS, AND PAYER DATA
Aug 11, 2026, 17:16 PM -
EQUITY IMPACT ANALYSIS OF SWITCHING FROM WHOLE-CELL PERTUSSIS ACELLULAR HEXAVALENT VACCINES IN LATINO AMERICAN COUNTRY: 2024
Aug 11, 2026, 17:16 PM -
COCHLEAR IMPLANTS FOR ADULTS WITH SINGLE-SIDED DEAFNESS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Aug 11, 2026, 17:16 PM -
STRUCTURED CARE PATHWAYS VERSUS HOME DELIVERY FOR TEMPERATURE-SENSITIVE BIOLOGICS IN IMMUNE-MEDIATED DISEASES: A REAL-WORLD PAYER ANALYSIS
Aug 11, 2026, 17:16 PM
